Join Now                                         Blog   LinkedIn   Twitter 

About the BGS

The British Geriatrics Society is the professional body of specialist doctors, nurses, therapists and other professionals concerned with the health care of older people in the United Kingdom.

Read more ...

May 2018 Newsletter

The May issue of the BGS newsletter is available:

Highlights
Should the BGS change its name?
The new geriatric giants
Normal pressure hydrocephalus: treatment seeks disease?

Call for Abstracts

Call for Abstracts for the BGS 2018 Autumn Meeting to be held in London in November 2018. The submissions facility closes at 17:00 on 15 June.

Read more ...

BGS President-Elect Elections 2018


In November, Professor Tahir Masud will succeed Dr Eileen Burns as BGS President. The BGS is opening the ballot to elect the next President-Elect.

Read more ...

Loneliness in older people

Register for this event on the impact of loneliness on health (13 June in London) 

NICE Quality Standard QS164 - Parkinson's Disease

This quality standard, published by NICE in February 2018, covers the management of Parkinson’s disease in adults. It does not include treatment of parkinsonism not caused by Parkinson’s disease. It describes high-quality care in priority areas for improvement.

Quality Statements:
Statement 1 Adults with Parkinson's disease have a point of contact with specialist services.

Statement 2 Adults with Parkinson's disease taking dopaminergic therapy are given information about the risk of impulse control disorders, when starting treatment and at least annually.

Statement 3 Adults with Parkinson's disease are referred to physiotherapy, occupational therapy or speech and language therapy if they have problems with balance, motor function, activities of daily living, communication, swallowing or saliva.

Statement 4 Adults with Parkinson's disease who are in hospital or a care home take levodopa within 30 minutes of their individually prescribed administration time.

Statement 5 Services for adults with Parkinson's disease provide access to clozapine and patient monitoring for treating hallucinations and delusions.

Search (mobile)

We use cookies to improve our website and your experience. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site